Bhutan vs Lithuania: The number of people with susceptibility test result for rifampicin
Bhutan
419
in 2021
Lithuania
465
in 2021
Bhutan rank
83rd
Lithuania rank
82nd
The number of people with susceptibility test result for rifampicin over time
- Bhutan
- Lithuania
How they compare
Lithuania currently reports 465 against 419 in Bhutan, a difference of 46.
That makes Lithuania's figure about 1.1 times Bhutan's.
Across all 5 years both countries report, Lithuania has been ahead every year.
Bhutan ranks 83rd and Lithuania ranks 82nd of 155 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 400.33 | 777 | 376.67 | Lithuania |
| 2020s | 426.5 | 474 | 47.5 | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bhutan or Lithuania?
- Lithuania, at 465 against 419 in Bhutan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bhutan and Lithuania?
- 46, with Lithuania ahead.
- How many years of comparable data are there for Bhutan and Lithuania?
- 5 years are reported by both, from 2017 to 2021.
- How do Bhutan and Lithuania rank globally for the number of people with susceptibility test result for rifampicin?
- Bhutan ranks 83rd and Lithuania ranks 82nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.